Charlton Aria Acquisition Corporation
NASDAQ:CHARShell Companies
-$0.01 today
- Market cap
- $120.94M
- Beta
- 0.03
- P/E (TTM)
- 30.8
- EPS (TTM)
- $0.35
Volume 0.00M
Average 0.01M
CHAR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Charlton Aria Acquisition CorporationNASDAQ: CHAR
Research & Development · Q4 FY2025 · quarter ended Dec 2025
Research & development remains negative
Q4 FY2025 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
Research & Development vs competitors
How CHAR compares with its peers on the latest reported figures
- CHAR's LTM Dec 2025 research & development of $0 is the highest of the 9 companies compared; the peer median is $0.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
CHARCharlton Aria Acquisition Corporation | LTM Dec 2025 | $0 | — | — | — |
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares | LTM Mar 2026 | $0 | — | — | — |
SPEGSilver Pegasus Acquisition Corp Class A Ordinary Shares | LTM Mar 2026 | $0 | — | — | — |
PGACPantages Capital Acquisition Corp | LTM Sep 2025 | $0 | — | — | — |
QUMSQuantumsphere Acquisition Corp. Ordinary Shares | LTM Dec 2025 | $0 | — | — | — |
QSEAQuartzsea Acquisition Corporation | FY2025 | $0 | — | — | — |
KVACKeen Vision Acquisition Corporation Ordinary Shares | LTM Mar 2026 | $0 | — | — | — |
| LTM Mar 2026 | $0 | — | — | — | |
FGMCFG Merger Corp. | LTM Mar 2026 | $0 | — | — | — |
| Peer median (excluding CHAR) | $0 | — | — | — | |
Competitors are the stored peer set for CHAR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 0 |
| Gross Profit | 0 | 0 |
| Gross Margin | — | — |
| Research & Development | 0 | 0 |
| Selling, General & Admin | 333 | 0 |
| Operating Expenses | 333 | 595.55K |
| Depreciation & Amortization | 333 | 0 |
| EBITDA | 0 | (595.55K) |
| EBITDA Margin | — | — |
| Operating Income | (332) | (595.55K) |
| Operating Margin | — | — |
| Interest Income | 660.24K | 3.58M |
| Interest Expense | 0 | 0 |
| Other Income / Expenses | 689 | 3.58M |
| Income Before Tax | 356 | 2.98M |
| Pre-Tax Margin | — | — |
| Income Tax Expense | 0 | 0 |
| Net Income | 356 | 2.98M |
| Net Margin | — | — |
| EPS (Basic) | 0.02 | 0.27 |
| EPS (Diluted) | 0.02 | 0.27 |
| Weighted Avg Shares | 10.97M | 8.5M |
| Weighted Avg Shares (Diluted) | 10.97M | 8.5M |
Charlton Aria Acquisition Corporation
NASDAQ:CHAR
Intrinsic Alpha fair value
Locked
Current Price
$11.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.